A new mRNA melanoma vaccine from Merck and Moderna showed sustained benefits over five years, cutting the risk of cancer recurrence or death by nearly half.

https://www.foxnews.com/health/could-cancer-vaccines-next-new-treatment-cuts-melanoma-risk-nearly-50